cysteine has been researched along with pci 32765 in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (62.50) | 24.3611 |
2020's | 3 (37.50) | 2.80 |
Authors | Studies |
---|---|
Cravatt, BF; Dix, MM; Douhan, J; Gilbert, AM; Hayward, MM; Hett, EC; Hulce, JJ; Johnson, TO; Joslyn, C; Kath, JC; Lanning, BR; Niessen, S; Roberts, LR; Schnute, ME; Wang, C; Wei, B; Whitby, LR; Whiteley, LO | 1 |
Sinha, G | 1 |
Berglöf, A; Blomberg, KE; Hamasy, A; Mohammad, DK; Smith, CI; Vihinen, M; Wang, Q; Yu, L | 1 |
Belmont, LD; Bergeron, P; Bowman, K; Burton, L; Choy, R; Crawford, JJ; Eigenbrot, C; Estevez, A; Franke, Y; Gogol, E; Johnson, AR; Katewa, A; Kohli, PB; Li, H; Lin, M; Mortara, K; Ortwine, DF; Penuel, E; Tam, C; Wu, J; Young, WB; Yu, C | 1 |
He, J; Li, H; Tang, B; Tang, P; Yang, H | 1 |
Berglöf, A; Estupiñán, HY; Mohammad, DK; Schaafsma, GCP; Shi, Y; Smith, CIE; Vihinen, M; Wang, Q; Yu, L; Zain, R; Zhou, L | 1 |
Atene, CG; Bonfiglio, S; Fiorcari, S; Forghieri, F; Ghia, P; Ljungström, V; Luppi, M; Maccaferri, M; Maffei, R; Marasca, R; Martinelli, S; Potenza, L; Scarfò, L; Tagliafico, E; Trenti, T; Zucchini, P | 1 |
Hamachi, I; Higashiguchi, K; Kawano, M; Matsuda, K; Murakawa, S; Tamura, T | 1 |
8 other study(ies) available for cysteine and pci 32765
Article | Year |
---|---|
A road map to evaluate the proteome-wide selectivity of covalent kinase inhibitors.
Topics: Adenine; Agammaglobulinaemia Tyrosine Kinase; Cell Line, Tumor; Cell Survival; Cysteine; Genes, erbB-1; Humans; Kinetics; Piperidines; Protein Kinase Inhibitors; Protein Kinases; Protein-Tyrosine Kinases; Proteome; Pyrazoles; Pyrimidines; Signal Transduction | 2014 |
Overcoming mantle cell lymphoma's ibrutinib resistance.
Topics: Adenine; Agammaglobulinaemia Tyrosine Kinase; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclin-Dependent Kinases; Cysteine; Drug Resistance, Neoplasm; Humans; Lymphoma, Mantle-Cell; Mutation; Piperazines; Piperidines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Purines; Pyrazoles; Pyridines; Pyrimidines; Quinazolinones; Serine | 2014 |
Substitution scanning identifies a novel, catalytically active ibrutinib-resistant BTK cysteine 481 to threonine (C481T) variant.
Topics: Adenine; Agammaglobulinaemia Tyrosine Kinase; Amino Acid Substitution; Animals; Biocatalysis; Cell Line; Cysteine; Drug Resistance, Neoplasm; Humans; Piperidines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrazoles; Pyrimidines; Threonine; Transfection | 2017 |
Battling Btk Mutants With Noncovalent Inhibitors That Overcome Cys481 and Thr474 Mutations.
Topics: Adenine; Agammaglobulinaemia Tyrosine Kinase; Antineoplastic Agents; Cysteine; Humans; Kinetics; Leukemia, Lymphocytic, Chronic, B-Cell; Mutation; Piperidines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrazoles; Pyrimidines; Threonine | 2016 |
Characterization of the binding of a novel antitumor drug ibrutinib with human serum albumin: Insights from spectroscopic, calorimetric and docking studies.
Topics: Adenine; Antineoplastic Agents; Binding Sites; Calorimetry; Circular Dichroism; Cysteine; Humans; Molecular Docking Simulation; Piperidines; Pyrazoles; Pyrimidines; Serum Albumin, Human; Spectroscopy, Fourier Transform Infrared | 2018 |
BTK gatekeeper residue variation combined with cysteine 481 substitution causes super-resistance to irreversible inhibitors acalabrutinib, ibrutinib and zanubrutinib.
Topics: Adenine; Agammaglobulinaemia Tyrosine Kinase; Animals; Benzamides; Cell Line; Cell Line, Tumor; Chickens; Chlorocebus aethiops; COS Cells; Cysteine; Drug Resistance, Neoplasm; HEK293 Cells; Humans; Mutation; Piperidines; Protein Kinase Inhibitors; Pyrazines; Pyrazoles; Pyrimidines; Threonine | 2021 |
A single-tube multiplex method for monitoring mutations in cysteine 481 of Bruton Tyrosine Kinase (BTK) gene in chronic lymphocytic leukemia patients treated with ibrutinib.
Topics: Adenine; Agammaglobulinaemia Tyrosine Kinase; Cysteine; Drug Resistance, Neoplasm; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Mutation; Piperidines; Protein Kinase Inhibitors | 2021 |
Lysine-Reactive
Topics: Agammaglobulinaemia Tyrosine Kinase; Cysteine; Lysine; Piperidines; Protein Kinase Inhibitors; Sulfanilamide; Sulfonamides | 2023 |